Filing Details
- Accession Number:
- 0001567619-21-021148
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-24 14:57:39
- Reporting Period:
- 2021-11-23
- Accepted Time:
- 2021-11-24 14:57:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1439725 | Biodesix Inc | BDSX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021413 | John Patience | 2970 Wilderness Place Suite 100 Boulder CO 80301 | Yes | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-23 | 10,000 | $6.18 | 1,940,367 | No | 4 | P | Indirect | By Patience Enterprises LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Patience Enterprises LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 58,597 | Direct | |
Common Stock | 2,811,353 | Indirect | By John Patience Living Trust dated 7/23/1993 |
Common Stock | 30,000 | Indirect | By Spouse |
Footnotes
- The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.74 to $6.38, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.